Wave Life Sciences (WVE) EBITDA Margin (QoQ) (2015 - 2025)
Wave Life Sciences (WVE) EBITDA Margin (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -6,367.00 |
| Jun 30, 2024 | 9,711.00 |
| Mar 31, 2024 | -21,053.00 |
| Dec 31, 2023 | -7,333.00 |
| Sep 30, 2023 | 11,521.00 |
| Jun 30, 2023 | 12,806.00 |
| Mar 31, 2023 | 328,174.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | -240,504.00 |
| Jun 30, 2022 | -906,693.00 |
| Mar 31, 2022 | -13,091.00 |
| Dec 31, 2021 | -202,501.00 |
| Sep 30, 2021 | 141,384.00 |
| Dec 31, 2020 | 67,639.00 |
| Sep 30, 2020 | 27,950.00 |
| Jun 30, 2020 | -7,557.00 |
| Mar 31, 2020 | 132,074.00 |
| Dec 31, 2019 | -67,246.00 |
| Sep 30, 2019 | -125,172.00 |
| Jun 30, 2019 | 98,784.00 |